Nigel Taylor
8Patents
6h-index
8Co-inventors
52Inventor score
Filing activity: Apr 9, 1997 → Feb 13, 2009
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6844437B1 | Process for the production of tert-butyl (E)-(6-[2-[4-(4-flurophenyl)-6-isopropyl-2-[methyl(methylsufonyl)amino]pyrimidin-5-yl]vinyl]4R,6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate | Emerging Cross-Sectional Technologies | 26 | Expired |
| US6784171B2 | Process for the production of tert-butyl (E)-(6-[2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl](4R,6S)-2, 2-dimethyl[1, 3]dioxan-4-yl)acetate | Emerging Cross-Sectional Technologies | 19 | Expired |
| US7511140B2 | Process for preparing the calcium salt of rosuvastatin | Human Necessities | 13 | Expired |
| US6841554B2 | Crystalline salts of 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid | Human Necessities | 11 | Expired |
| US6589959B1 | Crystalline bis[(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid]calcium salt | Human Necessities | 6 | Expired |
| US7129352B2 | Crystalline salts of 7-′4-(4-fluorophenyl) -6-isopropyl-2-′methyl (methylsulfonyl) amino!pyrimidin-5-yl!- (3R, 5S) -3, 5-dihydroxyhept-6-enoic acid | Human Necessities | 6 | Expired |
| US7842807B2 | Process for preparing the calcium salt of rosuvastatin | Human Necessities | 4 | Active |
| US5861516A | Process for preparing an antifungal azole with hydrazino and amidrazone intermediates | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.